Mettler-Toledo International Inc. (NYSE:MTD) Shares Bought by Carnegie Investment Counsel

Carnegie Investment Counsel increased its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 1.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,256 shares of the medical instruments supplier’s stock after buying an additional 205 shares during the quarter. Carnegie Investment Counsel’s holdings in Mettler-Toledo International were worth $17,444,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Parallel Advisors LLC grew its position in Mettler-Toledo International by 12.9% in the second quarter. Parallel Advisors LLC now owns 192 shares of the medical instruments supplier’s stock valued at $268,000 after acquiring an additional 22 shares in the last quarter. Citizens Financial Group Inc. RI acquired a new stake in Mettler-Toledo International during the 2nd quarter valued at $328,000. Renaissance Technologies LLC increased its stake in Mettler-Toledo International by 478.6% during the 2nd quarter. Renaissance Technologies LLC now owns 12,730 shares of the medical instruments supplier’s stock worth $17,791,000 after buying an additional 10,530 shares during the period. Axxcess Wealth Management LLC lifted its holdings in Mettler-Toledo International by 8.0% in the 2nd quarter. Axxcess Wealth Management LLC now owns 794 shares of the medical instruments supplier’s stock worth $1,110,000 after buying an additional 59 shares in the last quarter. Finally, Meiji Yasuda Life Insurance Co lifted its holdings in Mettler-Toledo International by 8.6% in the 2nd quarter. Meiji Yasuda Life Insurance Co now owns 543 shares of the medical instruments supplier’s stock worth $759,000 after buying an additional 43 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on MTD shares. Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Wells Fargo & Company dropped their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Stifel Nicolaus reduced their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,297.98 on Friday. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The business’s fifty day moving average price is $1,244.08 and its 200 day moving average price is $1,344.96. The stock has a market capitalization of $27.39 billion, a PE ratio of 35.00, a price-to-earnings-growth ratio of 3.83 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.